Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
ipo
3
×
biotech
boston blog main
boston top stories
life sciences
national blog main
new york blog main
new york top stories
acetylon pharmaceuticals
agios pharmaceuticals
ambys medicines
cancer
cancer drugs
cannabis
cell therapy
clinical trials
constellation pharmaceuticals
david e. shaw
deals
drug discovery
enasidenib
fda
gene therapy
genentech
holger willenbring
investing
ivosidenib
jeffrey tong
juan carlos izpisua belmonte
keith dionne
liver disease
markus grompe
martin burke
materials science
morphic
national top stories
new york
nimbus therapeutics
oregon stem cell center
privateer holdings
What
today
3
×
ipo
medicines
aiming
ambys
apiece
based
big
biotech
british
cannabis
closing
columbia
company
company’s
control
course
deadly
deal
debuted
development
discover
diseases
experimental
formed
future
governments
growing
handiwork
helped
high
internal
landscape
launch
liver
make
marijuana
medical
million
nasdaq
Language
unset
Current search:
ipo
×
today
×
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@techcrunch.com
5 years ago
Public shareholders got high today on Tilray, the first marijuana company to IPO on Nasdaq
